Company news
ValiRx PLC news in 2018
ValiRx PLC's news releases, calls and decks from 2018, newest first.
Issue of Equity / PDMR Shareholdings
December 18, 2018
Re scientific and investor meetings
November 5, 2018
ValiRx (VAL): VAL401 Phase II trial completed
November 1, 2018
Align Research Initiates Coverage
October 24, 2018
VAL201 in concluding stages of Phase I/II trial
October 17, 2018
VAL401 results shortly to be on ClinicalTrials.gov
October 15, 2018
Update on Clinical Development
September 6, 2018
US patent grant for therapeutic compound, VAL301
July 17, 2018
Notice of GM
July 6, 2018
VAL401 Update
June 14, 2018
Placing and grant of warrants
May 4, 2018
EU Patent Grant for Therapeutic Compound, VAL201
April 25, 2018
ValiRx (VAL): 2017: a pivotal year
April 20, 2018
GENEICE & VAL101 Update
April 19, 2018
US Patent Grant for Therapeutic Compound, VAL201
March 20, 2018
Statement re broker
March 2, 2018
Issue of options and directors dealings
February 9, 2018
ValiSeek Clinical Update (VAL401)
January 16, 2018
US Patent Notice of Allowance for Compound VAL201
January 11, 2018
Exercise of Warrants and Issue of Equity
January 3, 2018